Steve Schonfeld’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.36M Buy
+120,883
New +$1.61M 0.01% 1389
2025
Q3
– Sell
-25,150
Closed -$402K – 2246
2025
Q2
$402K Sell
25,150
-5,148
-17% -$91.8K ﹤0.01% 1609
2025
Q1
$589K Sell
30,298
-49,702
-62% -$1.05M ﹤0.01% 1514
2024
Q4
$1.76M Buy
+80,000
New +$1.54M 0.01% 887
2024
Q3
– Sell
-67,000
Closed -$801K – 2084
2024
Q2
$801K Buy
67,000
+24,700
+58% +$276K 0.01% 1296
2024
Q1
$469K Sell
42,300
-23,000
-35% -$235K ﹤0.01% 1499
2023
Q4
$565K Buy
65,300
+54,700
+516% +$425K ﹤0.01% 1242
2023
Q3
$81.1K Buy
+10,600
New +$79.6K ﹤0.01% 1509
2022
Q2
– Sell
-22,324
Closed -$143K – 2594
2022
Q1
$143K Buy
+22,324
New +$148K ﹤0.01% 2121

Other funds holding CLBT

Steve Schonfeld's CLBT Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Cellebrite (CLBT) in Q3 2026: 120,883 shares worth $1.36M. The stake represents 0.01% of the portfolio and ranks #1389 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in CLBT as recently as Q2 2025.

Steve Schonfeld first reported a position in CLBT in Q1 2022 and has held it in 9 quarters since. The position peaked at $1.76M in Q4 2024. 198 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.

  • Steve Schonfeld held 120,883 shares of Cellebrite worth $1.36M as of Q3 2026.
  • Cellebrite was a new Steve Schonfeld position in Q3 2026.
  • Cellebrite made up 0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1389 holding.
  • Steve Schonfeld first reported a position in Cellebrite in Q1 2022 and has held it in 9 quarters since.
  • Steve Schonfeld's Cellebrite position peaked at $1.76M in Q4 2024.
  • 198 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.